166 related articles for article (PubMed ID: 10095962)
1. [Prophylaxis of the experimental pseudotuberculosis infection by immunization with porin from Yersinia pseudotuberculosis].
Darmov IV; Marakulin IV; Pogorel'skiĭ IP; Novikova OD; Portniagina OIu; Solov'eva TF
Biull Eksp Biol Med; 1999 Feb; 127(2):221-3. PubMed ID: 10095962
[No Abstract] [Full Text] [Related]
2. [The protective properties of a porin from the outer membrane of Yersinia pseudotuberculosis].
Timchenko NF; Novikova OD; Pavlova TN; Venediktov VS; Solov'eva TF
Zh Mikrobiol Epidemiol Immunobiol; 1990 Nov; (11):48-50. PubMed ID: 1965874
[TBL] [Abstract][Full Text] [Related]
3. [Immunogenicity of B-antigen in experimental plague and pseudotuberculosis].
Byvalov AA; Krupin VV; Gavrilov KE
Zh Mikrobiol Epidemiol Immunobiol; 2006; (3):49-53. PubMed ID: 16830590
[TBL] [Abstract][Full Text] [Related]
4. [Immunochemical characteristics of synthetic peptides incorporating T- and B-cell epitopes nonspecific porins of pathogenic Yersinia].
Portniagina OIu; Sidorova OV; Novikova OD; Vostrikova OP; Khomenko VA; Solov'eva TF
Bioorg Khim; 2010; 36(6):779-88. PubMed ID: 21317944
[TBL] [Abstract][Full Text] [Related]
5. [Immunogenic and protective properties of nanosized constructs based on tubular immunostimulating complexes and pore forming protein of Yersinia pseudotuberculosis].
Tsybul'skiĭ AV; Popov AM; Sanina NM; Mazeĭka AN; Portniagina OIu; Novikova OD; Timchenko NF; Kostetskiĭ ÉIa
Zh Mikrobiol Epidemiol Immunobiol; 2011; (2):43-7. PubMed ID: 21598614
[TBL] [Abstract][Full Text] [Related]
6. [Dynamics of the immune response to porin from the outer membrane of Yersinia pseudotuberculosis].
Portniagina OIu; Novikova OD; Vostrikova OP; Solov'eva TF
Biull Eksp Biol Med; 1999 Oct; 128(10):437-40. PubMed ID: 10599505
[No Abstract] [Full Text] [Related]
7. Mutant OmpF porins of Yersinia pseudotuberculosis with deletions of external loops: structure-functional and immunochemical properties.
Sidorova OV; Khomenko VA; Portnyagina OY; Likhatskaya GN; Vakorina TI; Kim NY; Chistyulin DK; Solov'eva TF; Novikova OD
Biochem Biophys Res Commun; 2014 Mar; 445(2):428-32. PubMed ID: 24530904
[TBL] [Abstract][Full Text] [Related]
8. Studies on aerosol Yersinia pseudotuberculosis infection of guinea-pigs.
Velianov D; Nikolova S; Naĭdenski Kh; Raducheva T; Kŭsovski V; Grigoriev I; Ilieva L
Acta Microbiol Bulg; 1993; 30():3-10. PubMed ID: 8285130
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of an oral live vaccine for veterinary use against pseudotuberculosis.
Quintard B; Petit T; Ruvoen N; Carniel E; Demeure CE
Comp Immunol Microbiol Infect Dis; 2010 Dec; 33(6):e59-65. PubMed ID: 20034670
[TBL] [Abstract][Full Text] [Related]
10. IMMUNIZATION AGAINST PLAGUE BY A SPECIFIC FRACTION OF PASTEURELLA PSEUDOTUBERCULOSIS.
LAWTON WD; SURGALLA MJ
J Infect Dis; 1963; 113():39-42. PubMed ID: 14044091
[No Abstract] [Full Text] [Related]
11. [Use of porin from the outer membrane of Yersinia pseudotuberculosis for serodiagnosis of pseudotuberculosis].
Novikova OD; Portniagina OIu; Frolova GM; Solov'eva TF; Pavlova TN; Timchenko NF; Prokopenkova AP; Ovodov IuS
Biull Eksp Biol Med; 1995 Aug; 120(8):199-202. PubMed ID: 7579285
[No Abstract] [Full Text] [Related]
12. Production of recombinant porin from Y. pseudotuberculosis in a water-soluble form for pseudotuberculosis diagnostics.
Golotin V; Portnyagina O; Chopenko N; Kim N; Rasskazov V; Novikova O
Biol Chem; 2017 Oct; 398(11):1229-1236. PubMed ID: 28723607
[TBL] [Abstract][Full Text] [Related]
13. Protection against Yersinia pseudotuberculosis infection conferred by a Lactococcus lactis mucosal delivery vector secreting LcrV.
Daniel C; Sebbane F; Poiret S; Goudercourt D; Dewulf J; Mullet C; Simonet M; Pot B
Vaccine; 2009 Feb; 27(8):1141-4. PubMed ID: 19135495
[TBL] [Abstract][Full Text] [Related]
14. Non-Specific Porins of Yersinia pseudotuberculosis as Inductors of Experimental Hyperthyroidism in Mice.
Portnyagina OY; Golotin VA; Zelepuga EA; Khomenko VA; Shevchenko LS; Novikova OD
Bull Exp Biol Med; 2019 Apr; 166(6):751-753. PubMed ID: 31028578
[TBL] [Abstract][Full Text] [Related]
15. LcrV synthesis is altered by DNA adenine methylase overproduction in Yersinia pseudotuberculosis and is required to confer immunity in vaccinated hosts.
Badie G; Heithoff DM; Mahan MJ
Infect Immun; 2004 Nov; 72(11):6707-10. PubMed ID: 15501808
[TBL] [Abstract][Full Text] [Related]
16. YopE specific CD8+ T cells provide protection against systemic and mucosal Yersinia pseudotuberculosis infection.
González-Juarbe N; Shen H; Bergman MA; Orihuela CJ; Dube PH
PLoS One; 2017; 12(2):e0172314. PubMed ID: 28207901
[TBL] [Abstract][Full Text] [Related]
17. [The pathogenetic importance of Yersinia pseudotuberculosis lipopolysaccharide].
Kuznetsova TA; Besednova NN
Zh Mikrobiol Epidemiol Immunobiol; 1997; (5):37-41. PubMed ID: 9432844
[TBL] [Abstract][Full Text] [Related]
18. [Role of antibodies in protection from pseudotuberculous infection and intoxication].
Koroliuk AM
Zh Mikrobiol Epidemiol Immunobiol; 1978 Jul; (7):97-9. PubMed ID: 358704
[TBL] [Abstract][Full Text] [Related]
19. [Protective antigen of the pseudotuberculosis microbe].
Dzadzieva MF; Besednova NN; Snishchenko LA; Somov GP
Zh Mikrobiol Epidemiol Immunobiol; 1981 Jul; (7):71-5. PubMed ID: 7025531
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility to Yersinia pseudotuberculosis infection is linked to the pattern of macrophage activation.
Tansini A; de Medeiros BM
Scand J Immunol; 2009 Apr; 69(4):310-8. PubMed ID: 19284495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
